Remove 2001 Remove Patients Remove Treatment
article thumbnail

Serbian Patients Face Jail as Medical Marijuana Legalisation Stalls. so far 20 have gone to jail

Cannabis Law Report

Few medicines have helped him, but his condition drastically improved after he started treating himself with cannabis oil in 2001. “I Patients are in a terrible situation. Fifty-nine-year old Dragoljub Mrdjic has suffered from epilepsy for most of his life. I tried standard medicine, but there wasn’t much of a result.

Patients 105
article thumbnail

Mets Owner Steve Cohen Donates $5 Million in Support of Psychedelics Research

Veriheal

The donation was made through the Steven & Alexandra Cohen Foundation —an organization founded by the hedge fund billionaire in 2001 to promote philanthropy and community service. If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK – BMJ Report: ” Medical cannabis: patients turn to private clinics because of NHS void”

Cannabis Law Report

How will private clinics start seeing patients who request medical cannabis based products when NHS doctors seem unable to? They offer to treat patients for pain, cancer, and gastrointestinal, neurological, and psychiatric conditions. But why are these patients being left to seek treatment from the private sector?

article thumbnail

UK Article: Why Don’t We Just… reschedule psilocybin?

Cannabis Law Report

Psychedelic medicine could provide much needed treatment options for some mental health and neurological disorders in the near future. However, our drug laws impede research and deny patients access to these highly effective medicines. There are a number of differences between PAP and current treatment approaches.

article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

article thumbnail

Terpene Spotlight: Pulegone

FloridaMarijuana.net

Edition (2001): Medicinal plants contain a variety of bioactive compounds such as terpenes, which are composed of essential oils. The trained staff at the Medical Marijuana Treatment Center will assist each patient in selecting the appropriate cannabis products. According to P.M.

Terpenes 172
article thumbnail

Aspergillus: The Most Dangerous Cannabis Pathogen

Medicinal Genomics

Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list. Who is at risk?